Carina Cao

Genevest Consulting Group SA is an independent Swiss venture capital firm which was founded in 1983 to provide advisory services to institutional investors and high-net worth individuals. Based in Geneva, Genevest operates in close cooperation with Endeavour Vision SA.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

Gliatech, Inc. engages in the discovery and development of bio surgery and pharmaceutical products. The company was founded on August 12, 1987 and is headquartered in Cleveland, OH.

Genascence Corp. develops gene therapy products for musculoskeletal diseases. The company was founded by Dr. Annahita Keravala and Dr. Thomas W. Chalberg in 2017 and is headquartered in Palo Alto, CA.

Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL.

UF Innovate Ventures (UF Innovate Ventures) is a venture capital subsidiary of University of Florida founded in 2019. The firm is headquartered in Gainesville, Florida.

Deepwork Capital LLC (Deepwork Capital) is a venture capital firm founded in 2015 by Mitchel J. Laskey, Benjamin Patz and Kathy Chiu. The firm is headquartered in Orlando, Florida.

Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry.

Florida Technology Seed Capital Fund (Florida Technology) is a venture capital subsidiary of Institute for Commercialization of Florida Technology founded in 2011. The firm is headquartered in Tampa, Florida.

Institute for Commercialization of Florida Technology delivers company building and company funding programs to create products and companies. Its programs include company building, funding, executive council, third party solutions and startup quest. The company was founded in 2007 and is headquartered in Boca Raton, FL.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA.

keepMED Ltd. manufactures innovative devices for treating obstructive sleep apnea. It offers keePAP, a wearable device that comprises of a lightweight unobtrusive nasal interface and a miniature battery-operated control unit that is used for the treatment of obstructive sleep apnea. The company was founded by Rapoport Alex and is headquartered in Rishon Le Zion, Israel.

4see Ventures operates as a venture capital firm. It focuses in biotech, medtech and healthcare, technology, sustainable finance and new energy. The company was founded by Daniel Bertholet and is headquartered in Geneva, Switzerland.

CeQur SA develops medical devices for diabetes patients. It offers n insulin delivery device that provides three days of consistent, basal insulin deliver along with on-demand bolus insulin. The company was founded by James L. Peterson in January 2008 and is headquartered in Horw, Switzerland.